CD8A and neoplasm: The amount of DNA damage between the sonicated and control tumor with the relative localizations of CD8+ cells suggest that pFUS at 6 MPa results in a significant change toward an anti-tumoral TME (p < 0.05 ANOVA) in pFUS-treated B16 tumors at early time points and in more advanced pFUS-treated 4T1 tumors.